---
figid: PMC4983259__nihms-797946-f0002
figtitle: 'O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling'
organisms:
- Homo sapiens
- Mus musculus
- Caenorhabditis elegans
- Mouse mammary tumor virus
pmcid: PMC4983259
filename: nihms-797946-f0002.jpg
figlink: /pmc/articles/PMC4983259/figure/F1/
number: F1
caption: 'In left panel, the hexosamine pathway controls O-GlcNAcylation of nuclear
  and cytoplasmic proteins. A small fraction (2-5%) of glucose enters the HBP and
  fructose-6-phosphate is converted to glucosamine-6-phosphate by the rate-limiting
  enzyme of this pathway glutamine:fructose-6- amidotransferase (GFAT). UDP-N-acetylglucosamine
  (UDP-GlcNAc) is generated in subsequent steps and used as substrate by O-GlcNAc
  transferase (OGT) to add GlcNAc to serine or threonine residues of nuclear or cytoplasmic
  target proteins. O-GlcNAc modifications can be removed from proteins by the glycoside
  hydrolase O-GlcNAcase (OGA). In right panel, the receptor tyrosine kinase (RTK)-mediated
  signaling pathways converge on mTOR to regulate key transcription factors involved
  in cancer metabolism including HIF-1α, c-MYC, and SREBP-1. LKB1/AMPK negatively
  regulate mTOR pathway and metabolism. OGT and O-GlcNAcylation can intersect with
  this pathway at level of AMPK and regulation of key metabolic transcription factors
  HIF-1α and c-Myc. Abbreviations: HK2, hexokinase, PFKFB3, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase,
  isoform 3; PDK1, pyruvate dehydrogenase kinase, isozyme 1; PGK, phosphoglycerate
  kinase; PKM2, pyruvate kinase M2 isoform; LDHA, lactate dehydrogenase A; GLS1, glutaminae
  1; ACLY, ATP citrate lyase; FASN, fatty acid synthase; ACC1, acetyl-CoA carboxylase
  1.'
papertitle: 'O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.'
reftext: Christina M. Ferrer, et al. J Mol Biol. ;428(16):3282-3294.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9514914
figid_alias: PMC4983259__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Caenorhabditis elegans
redirect_from: /figures/PMC4983259__F1
ndex: ecb67816-def0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4983259__nihms-797946-f0002.html
  '@type': Dataset
  description: 'In left panel, the hexosamine pathway controls O-GlcNAcylation of
    nuclear and cytoplasmic proteins. A small fraction (2-5%) of glucose enters the
    HBP and fructose-6-phosphate is converted to glucosamine-6-phosphate by the rate-limiting
    enzyme of this pathway glutamine:fructose-6- amidotransferase (GFAT). UDP-N-acetylglucosamine
    (UDP-GlcNAc) is generated in subsequent steps and used as substrate by O-GlcNAc
    transferase (OGT) to add GlcNAc to serine or threonine residues of nuclear or
    cytoplasmic target proteins. O-GlcNAc modifications can be removed from proteins
    by the glycoside hydrolase O-GlcNAcase (OGA). In right panel, the receptor tyrosine
    kinase (RTK)-mediated signaling pathways converge on mTOR to regulate key transcription
    factors involved in cancer metabolism including HIF-1α, c-MYC, and SREBP-1. LKB1/AMPK
    negatively regulate mTOR pathway and metabolism. OGT and O-GlcNAcylation can intersect
    with this pathway at level of AMPK and regulation of key metabolic transcription
    factors HIF-1α and c-Myc. Abbreviations: HK2, hexokinase, PFKFB3, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase,
    isoform 3; PDK1, pyruvate dehydrogenase kinase, isozyme 1; PGK, phosphoglycerate
    kinase; PKM2, pyruvate kinase M2 isoform; LDHA, lactate dehydrogenase A; GLS1,
    glutaminae 1; ACLY, ATP citrate lyase; FASN, fatty acid synthase; ACC1, acetyl-CoA
    carboxylase 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mtor
  - Slc1a3
  - Pten
  - Pik3r1
  - Stk11
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Gfpt1
  - Ephb2
  - Mapk1
  - Akt1
  - Slc12a3
  - Tsc22d1
  - Rptor
  - Ogt
  - Oga
  - Eif4ebp1
  - Rps6kb1
  - Hif1a
  - Myc
  - Nol3
  - Srebf1
  - Hk2
  - Ldha
  - Pkm
  - Slc2a1
  - Pfkfb3
  - Pdk1
  - Pdpk1
  - Acly
  - Fasn
  - Acaca
  - MTOR
  - SLC2A1
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - STK11
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - GFPT1
  - GFPT2
  - APRT
  - MFAP1
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - OGT
  - EOGT
  - POMGNT1
  - POMGNT2
  - OGA
  - EIF4EBP1
  - RPS6KB1
  - HIF1A
  - MYC
  - SREBF1
  - HK2
  - KCNA5
  - KIF2A
  - KLK2
  - HOOK2
  - LDHA
  - PKM
  - PKLR
  - GLS
  - PFKFB3
  - PDK1
  - PDPK1
  - ACLY
  - FASN
  - ACACA
  - BCL2A1
  - H6PD
  - gls-1
  - pdk-1
  - acc-1
  - Fructose-6-P
  - Glucosamine-6-P
  - Glucose
  - Pentose Phosphate
  - Ser
  - UDP
  - Glu
  - Cancer
  - Lung cancer
---
